Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1993
06/10/1993WO1993010785A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
06/10/1993WO1993010784A1 Therapeutic composition and method for preventing reperfusion injury
06/10/1993WO1993010783A2 Quinolone derivatives and their use as ampa and nmda receptor antagonists
06/10/1993WO1993010782A1 Pharmaceutical compositions based on ebastime or analogues thereof
06/10/1993WO1993010781A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
06/10/1993WO1993010780A1 Heterocyclic-substituted pyridine compounds and uses
06/10/1993WO1993010779A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
06/10/1993WO1993010778A1 Inhibition of angiogenesis with pyridinyloxazole-2-ones
06/10/1993WO1993010777A1 Composition and method for reducing free radical cellular oxidative stress in warm-blooded animals
06/10/1993WO1993010776A1 Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
06/10/1993WO1993010775A1 Process and composition for the development of controlled release gemfibrozil dosage form
06/10/1993WO1993010774A1 Anti-hbv pyrimidine nucleoside
06/10/1993WO1993010773A1 Use of neutral endopeptidase inhibitors in the treatment of left ventricular hypertrophy
06/10/1993WO1993010772A1 Transdermal estradiol delivery system
06/10/1993WO1993010771A1 Slow-release flurbiprofen-containing medicament and its use
06/10/1993WO1993010770A1 Slow-release medicament containing a dihydropyridine derivate as a nanosol and its preparation
06/10/1993WO1993010769A1 Slow-release pharmaceutic form of a medicament containing 3-indolylacetic acid derivate and its preparation
06/10/1993WO1993010766A1 Immediate-effect flurbiprofen-containing medicament and its use
06/10/1993WO1993010762A1 Immediate-effect ibuprofen-containing medicament and its use
06/10/1993WO1993010761A1 Medicament containing a 2-arylpropionic acid derivate as a nanosol and its preparation
06/10/1993WO1993010760A1 Slow-release ibuprofen-containing medicament and its use
06/10/1993WO1993010757A1 Pharmaceutical composition
06/10/1993WO1993010756A1 Use of salicylic acid for regulating skin wrinkles and/or skin atrophy
06/10/1993WO1993010755A1 Compositions for regulating skin wrinkles and/or skin atrophy
06/10/1993WO1993010754A1 Skin care composition
06/10/1993WO1993010742A2 Chemical compounds, their preparation and use
06/10/1993WO1993010741A2 Sex steroid activity inhibitors
06/10/1993WO1993008808A3 Use of gangliosides in the preparation of pharmaceuticals which can improve the progonosis of disorders due to psychotropics and drugs abuse
06/10/1993WO1993003714A3 Method for treatment of metabolic disorders
06/10/1993CA2125167A1 Method of reducing medical device related infections
06/10/1993CA2125156A1 Pharmaceutical composition
06/10/1993CA2125149A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
06/10/1993CA2124944A1 Skin care composition
06/10/1993CA2124852A1 Use of a known chemical compound for the production of a pharmaceutical composition for topical application
06/10/1993CA2124445A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
06/10/1993CA2124444A1 Methods and compositions for treating infection using optically pure (r)-lomefloxacin
06/10/1993CA2124443A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
06/10/1993CA2124209A1 A new preparation with an acrylic-based adhesive copolymeric matrix for the transdermal delivery of estradiol
06/10/1993CA2124204A1 Composition and method for reducing free radical cellular oxidative stress in warm-blooded animals
06/10/1993CA2123678A1 Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
06/10/1993CA2123677A1 Process and composition for the development of controlled release gemfibrozil dosage form
06/10/1993CA2123516A1 Organic salts of n,n'-diacetyl cystine
06/10/1993CA2123216A1 Novel n-hydroxyalkyl-substituted 1,2,3,6-tetrahydropyridine and piperidine derivatives
06/10/1993CA2123207A1 Multiple solvent cleaning system
06/10/1993CA2122992A1 Leukotriene-b derivatives, process for preparing the same and medicaments
06/10/1993CA2122916A1 1-amino-2-[(benzothiazolyl)methyl] spiro [isoquinoline-4(1h),3'-pyrrolidine]-1,2',3,5'(2h)- tetrones and analogs thereof useful as aldose reductase inhibitors
06/10/1993CA2122841A1 Quinolone derivatives
06/10/1993CA2122840A1 Quinolone derivatives
06/10/1993CA2122614A1 Antiparasitic agents
06/10/1993CA2121904A1 Dimeticon pastilles
06/10/1993CA2117304A1 Chemical compounds, their preparation and use
06/10/1993CA2084736A1 Benzofuranes
06/10/1993CA2084542A1 Novel azaheterocyclylmethyl-chromans
06/10/1993CA2084541A1 Piperidylmethyl-substituted chroman derivatives
06/10/1993CA2084334A1 Triazole derivatives and salts thereof, processes for producing the same, and antifungal agent containing the same
06/10/1993CA2083416A1 Oligodeoxyribonucleotides having anti-ischemic activity and methods of preparation thereof
06/10/1993CA2057289A1 Pharmaceutical preparation for inhibiting the replication of various viruses
06/09/1993EP0545913A1 Delivery systems for pharmacological agents
06/09/1993EP0545912A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use
06/09/1993EP0545892A1 Pesticidal compounds
06/09/1993EP0545891A2 Aldehyde compounds and derivatives thereof useful as intermediates in the preparation of insectical ether compounds
06/09/1993EP0545845A1 Imidazole compounds, their preparation and use as calcium channel blockers
06/09/1993EP0545805A1 Use of D-fenfluramine and fenfluramine derivatives in the treatment of hypertension in insulin-resistant patients
06/09/1993EP0545759A1 Use of a sulfur containing amino acid, eventually in combination with pyridoxine, for the preparation of a medicament for the treatment of eczema
06/09/1993EP0545582A1 Improved fish production
06/09/1993EP0545511A2 Process for the preparation of mono-N-substituted tetraazamacrocycles
06/09/1993EP0545478A1 Heterocyclic compounds as tachykinin antagonists
06/09/1993EP0545441A1 Substituted benzoylurea derivatives or their salts, processes for their production and antitumor compositions containing them
06/09/1993EP0545425A1 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments
06/09/1993EP0545421A1 4-(4-piperidinyl-thieno(3,2-c)pyridine derivatives of N-alkylglutarimides as antipsychotic agents
06/09/1993EP0545413A1 Novel trans cyclopentanyl purine analogs useful as immunosuppressants
06/09/1993EP0545376A1 Guanidino thiazoles and their use as H2-receptor antagonist
06/09/1993EP0545212A1 Use of glucocorticoid monoesters, especially dexamethasone-in-sulfobenzoate, for the preparation of a parenterally applicable medicament for the treatment of diseases for which glucocorticoids are indicated
06/09/1993EP0545195A1 Indolopyrrolocarbazole derivatives
06/09/1993EP0545171A1 Quinolylmethoxyphenyl acetic acid acylamides and ureas
06/09/1993EP0545170A1 Quinolylmethoxyphenylacetamides
06/09/1993EP0545147A2 Use of radical scavengers and/or substances suitable for deactivating nonradical reactive oxygen species for preventing or delaying human hair greying
06/09/1993EP0545120A2 Combination of 5-HT2-receptor antagonists and 5-HT1A-receptor agonists with neuroprotective effect
06/09/1993EP0545095A1 1,3-Substituted cycloalkenes and cycloalkanes as central nervous system agents
06/09/1993EP0544909A1 Tricyclic benzodiazepine derivates their preparation and pharmaceutical compositions containing them
06/09/1993EP0544907A1 Antibacterial penem esters derivatives
06/09/1993EP0544906A1 Penem compounds
06/09/1993EP0544905A1 Antibacterial penem compounds
06/09/1993EP0544900A1 Transdermal nicotine absorption dosage unit and process
06/09/1993EP0544899A1 Prostaglandins.
06/09/1993EP0544880A1 Method of preparing diacetyl rhein.
06/09/1993EP0544878A1 Asialoglycoprotein-conjugated medicinal agent
06/09/1993EP0544815A1 Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates
06/09/1993EP0544812A1 Bisphosphonic acid derivatives as anti-arthritic agents.
06/09/1993EP0544779A1 Heterocyclic compounds and their preparation and use
06/09/1993EP0544773A1 Azabicyclic compounds, process and intermediates for their preparation and pharmaceutical compositions containing them
06/09/1993EP0544756A1 1,2,5,6-tetrahydro-1-methylpyridines, their preparation and use
06/09/1993EP0544716A1 Oligonucleotide modulation of cell adhesion
06/09/1993EP0544705A1 Derivatives of mupirocin
06/09/1993EP0544681A1 A novel salicylic acid-maltol conjugates.
06/09/1993EP0544668A1 -6-fluoro-9-(2,3-dideoxy-b-d-glycero-pentofuranosyl)-9h-purines and their use asantiviral agents
06/09/1993EP0531452A4 Synthesis of glycerol di- and triphosphate derivatives
06/09/1993EP0478708A4 Formation of triple helix complexes of double stranded dna using nucleoside oligomers
06/09/1993EP0437451B1 Finely divided solid crystalline powders via precipitation into an anti-solvent
06/09/1993EP0358657B1 Poly(deoxyribonucleotides), pharmaceutical compositions, use and preparation of the poly(deoxyribonucleotides)
1 ... 7187 7188 7189 7190 7191 7192 7193 7194 7195 7196 7197 7198 7199 7200 7201 7202 7203 7204 7205 7206 7207 ... 7860